Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKesson
AstraZeneca
Express Scripts
Colorcon

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR DEXTROAMPHETAMINE SULFATE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Dextroamphetamine Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000304 ↗ Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 Completed University of Texas Phase 2 1997-08-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
NCT00000304 ↗ Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1997-08-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
NCT00000306 ↗ Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 Completed University of Texas Phase 2 1994-09-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
NCT00000306 ↗ Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-09-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
NCT01886469 ↗ A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) Completed Ironshore Pharmaceuticals and Development, Inc Phase 1/Phase 2 2013-07-01 The main purpose of this study is to determine the rate and extent of absorption of one or more modified release formulations of amphetamine (HLD100) in both adolescents and children with ADHD.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dextroamphetamine Sulfate

Condition Name

Condition Name for Dextroamphetamine Sulfate
Intervention Trials
ADHD 2
Cocaine-Related Disorders 2
Narcolepsy 2
Psychosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dextroamphetamine Sulfate
Intervention Trials
Disease 4
Cocaine-Related Disorders 2
Hyperkinesis 2
Attention Deficit Disorder with Hyperactivity 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dextroamphetamine Sulfate

Trials by Country

Trials by Country for Dextroamphetamine Sulfate
Location Trials
United States 4
Canada 3
Austria 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dextroamphetamine Sulfate
Location Trials
Texas 2
Utah 1
Nevada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dextroamphetamine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Dextroamphetamine Sulfate
Clinical Trial Phase Trials
Phase 2 4
Phase 1/Phase 2 1
Phase 1 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dextroamphetamine Sulfate
Clinical Trial Phase Trials
Completed 5
Recruiting 2
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dextroamphetamine Sulfate

Sponsor Name

Sponsor Name for Dextroamphetamine Sulfate
Sponsor Trials
University of Texas 2
National Institute on Drug Abuse (NIDA) 2
Ironshore Pharmaceuticals and Development, Inc 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dextroamphetamine Sulfate
Sponsor Trials
Other 6
NIH 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Johnson and Johnson
Boehringer Ingelheim
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.